| Literature DB >> 21426660 |
Xia Liu1, Jun Zhao, Rengyun Liu, Zhe Lei, Jiacong You, Qinghua Zhou, Hong-Tao Zhang.
Abstract
BACKGROUND ANDEntities:
Mesh:
Substances:
Year: 2011 PMID: 21426660 PMCID: PMC5999654 DOI: 10.3779/j.issn.1009-3419.2011.03.04
Source DB: PubMed Journal: Zhongguo Fei Ai Za Zhi ISSN: 1009-3419
hOGG1启动子区PCR引物及SSCP条件
PCR primers used for the promoter of hOGG1 and SSCP conditions
| No. | Primer sequence (5’→ 3’) | Product length | Incubate temp (T) | SSCP conditions | ||
| Concentration of PAGE gel | Electrophoresis time | |||||
| SSCP: single-strand conformation polymorphism; FP: forward primer; RP: reverse primer. | ||||||
| 1 | FP | TCCCTTCTCTTTCCCATAGATTCC | 209 bp | 56.0 ℃ | 8% | 4.5 h |
| RP | CATGCACAGCAGTCAGCAACC | |||||
| 2 | FP | AGTGGTTGCTGACTGCTGTGC | 257 bp | 57.0 ℃ | 8% | 5 h |
| RP | CAGACCTGGGTTCCAATTCTAGC | |||||
| 3 | FP | AGAGCTAGAATTGGAACCCAGG | 223 bp | 54.5 ℃ | 8% | 5 h |
| RP | GGTGAGCAAAGAGCAACCG | |||||
| 4 | FP | ACAGAGCTGGGATGGAGACG | 253 bp | 58.0 ℃ | 8% | 5 h |
| RP | AGAGACCTAGCGGAGTGTACCG | |||||
| 5 | FP | CTAGGTCTCTGGCTGGGACACAAGG | 273 bp | 61.5 ℃ | 8% | 5 h |
| RP | CGGGTTCAAGCGATTCTCCTGC | |||||
| 6 | FP | AGGAGAATCGCTTGAACCCG | 265 bp | 58.6 ℃ | 8% | 5 h |
| RP | TCTAGTCGCCTGGAGTAGGAGG | |||||
| 7 | FP | ATCCATCCTCCTACTCCAGGCG | 151 bp | 58.0 ℃ | 8% | 4 h |
| RP | CATACTCCATCTGCTCATGCTTTCC | |||||
| 8 | FP | CCGAGGAAAGCATGAGCAGATGG | 247 bp | 59.1 ℃ | 6% | 5 h |
| RP | AACCCTGTCTTCACCAAGAACCGG | |||||
| 9 | FP | TGGTGAAGACAGGGTTCGTGGG | 305 bp | 60.6 ℃ | 8% | 5.5 h |
| RP | TAGCCAATCCGAGGAGGAGGTAGG | |||||
| 10 | FP | GGCTACCTCTAGGTGAAATGAGCGG | 272 bp | 61.0 ℃ | 8% | 5.5 h |
| RP | CCCACACGGTGCTGTTTAACAACC | |||||
| 11 | FP | ACAGGGAAGGTTGTTAAACAGCACC | 266 bp | 59.0 ℃ | 8% | 5 h |
| RP | CCGGAAAGATTGTCCAGAAGGC | |||||
1hOGG1第2对引物PCR扩增产物的SSCP和DNA测序。A:SSCP分析显示:8、9、11、16号样本呈三条带,其余为两条带;B:两条带PCR产物测序结果显示在-2096 bp处的基因型为T/T,三条带为T/C
SSCP analysis and DNA sequencing for PCR product amplified by No.2 pair of primers. A: SSCP analysis shows an altered pattern with three bands in samples 8, 9, 11 and 16, and a normal pattern with two bands in other samples; B: DNA sequencing reveals that samples with three bands have T/C allele and those with two bands have T/T allele at the site -2096 bp
2hOGG1第11对引物PCR扩增产物的SSCP和DNA测序。A:SSCP分析显示:6、14号样本呈三条带,15号四条带,其余为两条带;B:两条带PCR产物测序结果显示在-18 bp处的基因型为G/G,三条带为G/T;两条带PCR产物测序结果显示在-23 bp处的基因型为A/A,四条带为A/G
SSCP analysis and DNA sequencing for PCR product amplified by No.11 pair of primers. A: SSCP analysis shows altered patterns with three bands in samples 6, 14 and four bands in sample 15, and a normal pattern with two bands in other samples; B: DNA sequencing reveals that samples with three bands have G/T allele and those with two bands have G/G allele at the site -18 bp, and the sample with four bands have A/G allele and those with two bands have A/A allele at the site -23 bp
40例NSCLC患者中rs159153多态基因型与临床病理特征的关系
Associations between SNP rs159153 and clinical characteristics in 40 NSCLCs
| Characteristic | Genotype | ||
| rs159153(T/T) | rs159153(T/C) | ||
| * | |||
| Gender | 1.000 | ||
| Male | 22 | 6 | |
| Female | 9 | 3 | |
| Age (year) | 0.476 | ||
| ≤60 | 16 | 6 | |
| >60 | 15 | 3 | |
| Smoking history | 0.399 | ||
| Yes | 10 | 1 | |
| No | 21 | 8 | |
| Histology | 0.898 | ||
| Adenocarcinoma | 12 | 4 | |
| Squamous cell carcinoma | 13 | 3 | |
| Other types | 6 | 2 | |
| Primary tumor | 0.097 | ||
| T1+T2 | 24 | 4 | |
| T3+T4 | 7 | 5 | |
| Lymph node OMs | 0.712 | ||
| N0 | 17 | 4 | |
| N1+N2+N3 | 14 | 5 | |
| TNM Stage | 0.008 | ||
| Ⅰ+Ⅱ | 28 | 4 | |
| Ⅲ+Ⅳ | 3 | 5 | |
| Total | 31 | 9 | |
40例NSCLC患者中临床病理特征与吸烟史的关系
Associations between clinical characteristics and smoking history in 40 NSCLCs
| Characteristic | Smoking history | ||
| Yes | No | ||
| * | |||
| Gender | 0.124 | ||
| Male | 10 | 18 | |
| Female | 1 | 11 | |
| Age (year) | 0.173 | ||
| ≤60 | 4 | 18 | |
| >60 | 7 | 11 | |
| Histology | 0.027 | ||
| Adenocarcinoma | 1 | 15 | |
| Other types | 10 | 14 | |
| Genotype | 0.399 | ||
| rs159153(T/T) | 10 | 21 | |
| rs159153(T/C) | 1 | 8 | |
| Primary tumor | 0.254 | ||
| T1+T2 | 6 | 22 | |
| T3+T4 | 5 | 7 | |
| Lymph node OMs | 0.03.4 | ||
| N0 | 9 | 12 | |
| N1+N2+N3 | 2 | 17 | |
| TNM Stage | 0.080 | ||
| Ⅰ+Ⅱ | 11 | 21 | |
| Ⅲ+Ⅳ | 0 | 8 | |
| Total | 31 | 9 | |